Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
PACB Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
10.90%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
21.20%
PACB Stock Analysis
PACB
PE Ratio:
PACB
PEG Ratio:
Not Available
PACB
Forward EPS Growth (12 month):
0.00%
PACB
PS Ratio:
3.1
PACB
PSG Ratio:
0.2
PACB
Forward Revenue Growth (12 month):
13.80%
PACB Articles
No data was found